Journal of Clinical and Analytical Medicine, vol.7, no.1, pp.35-37, 2016 (Scopus)
Portal vein thrombosis (PVT) is a rare but serious complication in liver cirrho-sis. Eltrombopag is a new, second generation agent used for immune throm-bocytopenic purpura (ITP). It may cause thrombotic events. PVT has been rarely reported as a life threatening complication in some cirrhotic patients during eltrombopag using. We presented 63 years old cirrhotic and immune thrombocytopenic patient who had PVT after eltrombopag.